Glenview Trust’s National Healthcare NHC Stock Holding History

Glenview Trust’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,000	Closed	-$523K	–	463
2023 Q1	$523K	Buy	+9,000	New	+$517K	0.02%	312

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Glenview Trust's NHC Position: Q2 2023 in Review

Glenview Trust sold out of National Healthcare (NHC) in Q2 2023, closing a stake of 9,000 shares — an estimated $523K sold.

Glenview Trust first reported a position in NHC in Q1 2023 and held it in 1 quarter. The position peaked at $523K in Q1 2023. 132 funds tracked by Wall St. Rank hold NHC as of Q2 2023.

Glenview Trust reported no remaining National Healthcare position as of Q2 2023 after selling out during the quarter.
Glenview Trust sold 9,000 National Healthcare shares in Q2 2023, an estimated $523K.
Glenview Trust first reported a position in National Healthcare in Q1 2023 and held it in 1 quarter.
Glenview Trust's National Healthcare position peaked at $523K in Q1 2023.
132 funds tracked by Wall St. Rank held National Healthcare as of Q2 2023.

Based on Glenview Trust's 13F filing for Q2 2023, filed 14 Aug 2023.